Dingdang Health Technology Group Ltd. (HKG:9886)
Hong Kong · Delayed Price · Currency is HKD 0.9200
+0.0400 (4.55%)
Sep 12, 2025, 3:40 PM HKT
HKG:9886 Revenue
Dingdang Health Technology Group had revenue of 2.33B CNY in the half year ending June 30, 2025, with 3.54% growth. This brings the company's revenue in the last twelve months to 4.73B, down -3.06% year-over-year. In the year 2024, Dingdang Health Technology Group had annual revenue of 4.67B, down -3.87%.
Revenue (ttm)
4.73B CNY
Revenue Growth
-3.06%
P/S Ratio
0.22
Revenue / Employee
2.00M CNY
Employees
2,363
Market Cap
1.16B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.67B | -187.73M | -3.87% |
| Dec 31, 2023 | 4.86B | 527.73M | 12.19% |
| Dec 31, 2022 | 4.33B | 650.39M | 17.68% |
| Dec 31, 2021 | 3.68B | 1.45B | 65.07% |
| Dec 31, 2020 | 2.23B | 952.97M | 74.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines AG | 35.81B |
| JD Health International | 71.34B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |
| Sino Biopharmaceutical | 33.49B |
| WuXi Biologics | 21.98B |
| Akeso | 2.75B |
| Alibaba Health Information Technology | 32.81B |